Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $63.5 million.

  • Treace Medical Concepts' Shares Outstanding (Weighted Average) rose 206.64% to $63.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.5 million, marking a year-over-year increase of 206.64%. This contributed to the annual value of $62.1 million for FY2024, which is 207.04% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Shares Outstanding (Weighted Average) is $63.5 million, which was up 206.64% from $63.0 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Shares Outstanding (Weighted Average) ranged from a high of $63.5 million in Q3 2025 and a low of $37.9 million during Q1 2021
  • For the 5-year period, Treace Medical Concepts' Shares Outstanding (Weighted Average) averaged around $57.3 million, with its median value being $60.9 million (2023).
  • As far as peak fluctuations go, Treace Medical Concepts' Shares Outstanding (Weighted Average) surged by 4483.72% in 2022, and later surged by 108.34% in 2024.
  • Over the past 5 years, Treace Medical Concepts' Shares Outstanding (Weighted Average) (Quarter) stood at $48.4 million in 2021, then grew by 14.17% to $55.3 million in 2022, then increased by 10.09% to $60.9 million in 2023, then rose by 2.07% to $62.1 million in 2024, then grew by 2.26% to $63.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $63.5 million in Q3 2025, compared to $63.0 million in Q2 2025 and $62.7 million in Q1 2025.